NanoViricides
Stock Forecast, Prediction & Price Target

NanoViricides Financial Estimates

NanoViricides Revenue Estimates

NanoViricides EBITDA Estimates

NanoViricides Earnings per Share Estimates

Passed Analyst forecast
Metric 6/30/2022 6/30/2023 6/30/2024 6/30/2026 6/30/2027
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $3M
Low: $3M
High: $3M
avg. 0%
Avg: $7M
Low: $7M
High: $7M
avg. 133.33%
Net Income
 
% change YoY
$-8.10M
 
N/A
$-8.58M
 
-6.03%
$-8.29M
 
3.42%
Avg: $-12.90M
Low: $-12.90M
High: $-12.90M
avg. -55.59%
Avg: $-4.41M
Low: $-4.41M
High: $-4.41M
avg. 65.76%
EBITDA
 
% change YoY
$-7.37M
 
N/A
$-7.84M
 
-6.25%
$-7.75M
 
1.05%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.7
 
N/A
-$0.74
 
-5.71%
-$0.7
 
5.40%
Avg: -$1.11
Low: -$1.11
High: -$1.11
avg. -58.57%
Avg: -$0.38
Low: -$0.38
High: -$0.38
avg. 65.76%
Operating Expenses
 
% change YoY
$8.11M
 
N/A
$8.94M
 
10.22%
$8.51M
 
-4.77%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is NanoViricides stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 5.08% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is -12.90M, average is -12.90M and high is -12.90M.

What is NanoViricides stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 66.66% in 2026-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $3M, average is $3M and high is $3M.

What is NanoViricides stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 3.59% in 2026-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.11, average is -$1.11 and high is $-1.11.